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Background: Video-laryngoscopes are marketed for intubation in difficult airway management. They provide a better
view of the larynx and may facilitate tracheal intubation, but there is no adequately powered study comparing different
types of video-laryngoscopes in a difficult airway scenario or in a simulated difficult airway situation.
Methods/Design: The objective of this trial is to evaluate and to compare the clinical performance of three video-
laryngoscopes with a guiding channel for intubation (Airtraq™, A. P. Advance™, King Vision™) and three video-
laryngoscopes without an integrated tracheal tube guidance (C-MAC™, GlideScope™, McGrath™) in a simulated difficult
airway situation in surgical patients. The working hypothesis is that each video-laryngoscope provides at least a 90%
first intubation success rate (lower limit of the 95% confidence interval >0.9). It is a prospective, patient-blinded,
multicenter, randomized controlled trial in 720 patients who are scheduled for elective surgery under general
anesthesia, requiring tracheal intubation at one of the three participating hospitals. A difficult airway will be created
using an extrication collar and taping the patients’ head on the operating table to substantially reduce mouth opening
and to minimize neck movement. Tracheal intubation will be performed with the help of one of the six devices
according to randomization. Insertion success, time necessary for intubation, Cormack-Lehane grade and percentage of
glottic opening (POGO) score at laryngoscopy, optimization maneuvers required to aid tracheal intubation, adverse
events and technical problems will be recorded. Primary outcome is intubation success at first attempt.
Discussion: We will simulate the difficult airway and evaluate different video-laryngoscopes in this highly realistic and
clinically challenging scenario, independently from manufacturers of the devices. Because of the sufficiently powered
multicenter design this study will deliver important and cutting-edge results that will help clinicians decide which
device to use for intubation of the expected and unexpected difficult airway.
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Difficult airway management remains a cornerstone of clin-
ical anesthesiology. Difficulty in tracheal intubation is the
most common factor related to serious airway complications
during general anesthesia [1]. Recently, the combination of
the fiberoptic bronchoscope and the laryngoscope led to the
development of video-laryngoscopes, providing a video-
based view of the glottic opening, with or without additional
guidance of the tube towards the tracheal opening. Six de-
vices are under prominent focus in recent publications.
1) The Airtraq (Prodol Meditec SA, Vizcaya, Spain)
was the first video intubation device that featured a
channel guiding the tube towards the tracheal
opening. The blade of the Airtraq is disposable. One
study published in 2007 in Anesthesiology showed a
100% success rate at first attempt when using
manual inline stabilization [2].
2) The A. P. Advance Video-laryngoscope (Venner
Medical SA, Singapore) is based on a standard
Macintosh laryngoscope that can be used as a stand-
alone direct laryngoscope, or as a video-
laryngoscope with a monitor attached to the handle
and includes a “difficult airway” blade. A manikin
study showed short intubation times for certified
paramedics with the A.P. Advance [3], but large
adequately powered, randomized controlled trials in
difficult airway scenarios are lacking.
3) The C-MAC (Karl Storz, Tuttlingen, Germany)
features size 2, 3 or 4 Macintosh blades or a “D”-
blade (Difficult Airway Blade). The D-blade failed at
first attempt in 30% of patients who showed a
Cormack-Lehane grade 3 or 4 in a study by the
inventor of the design [4]. One study shows a 93%
success rate with the C-MAC using size 3 and 4
blades, compared to 84% for direct laryngoscopy
when using manual inline stabilization, but
intubation took longer [5].
4) The GlideScope (Verathon Inc., Bothell, WA, USA)
is a widely used non-guided video-laryngoscope
consisting of a curved video blade (single-use or
reusable) and a special stylet to be used with the
tracheal tube. An observational study in 50 patients
showed a 100% success rate of the GlideScope in a
difficult airway model using stiff extrication collars
[6]. It also reduced intubation times compared with
the conventional Macintosh laryngoscope in patients
under manual inline stabilization [7].
5) The King Vision (Kingsystems, Noblesville, IN,
USA) features either a channeled or a regular,
disposable blade size 3. To date, there are no
randomized controlled trials available for this device.
6) The McGrath MAC (Aircraft Medical Lt.,
Edinburgh, UK) is a non-guided video-laryngoscopethat features disposable blades. It has been
developed from the McGrath Series 5. In a
randomized controlled trial with patients with a
Mallampati grade of ≥3, the McGrath Series 5
provided a better laryngeal view compared to the
C-MAC, but intubation took longer and more
intubation attempts where needed [8]. To date,
there are no randomized controlled trials available
for the McGrath MAC video-laryngoscope.
These optical intubation devices or video-laryngoscopes
(VLS) have dramatically improved the quality of glottic
visualization. Multiple studies have proven enhanced visi-
bility but not necessarily faster intubation times. Interest-
ingly, in a study on manikins simulating difficult airway
with stiff collars, VLS was not superior to direct laryngos-
copy, but the sample size was low [9]. Furthermore, while
VLS improve visualization of the airway, it is important to
realize that a good view of the laryngeal opening does not
automatically lead to intubation success. For example, in a
recent study, the C-MAC VLS showed a good view of the
larynx in 95% of cases, but the actual success rate of the
intubation was only 88% [10]. These different success rates
cannot directly be compared since these studies were
performed in different patient populations by different op-
erators, in different settings regarding difficult airways,
and with different outcome parameters. Most importantly,
the majority of patients enrolled presented with a normal
airway, or only manual inline stabilization was used to
simulate a difficult airway. No study compared all these
devices in the same setting, and no sufficiently powered
study used extrication collars to adequately simulate a
clinically important difficult airway situation.
Specific aims of the study are:
1) To investigate which VLS devices reach a clinically
acceptable minimal first attempt success rate of 90%
in a simulated difficult airway scenario (primary
outcome). We assume this lower limit of “90% first
attempt success rate” is the lowest tolerable success
rate in a difficult airway scenario.
2) To compare primary and overall success rates, view
on the tracheal opening and time until intubation
with the help of the guided vs. unguided VLS
devices.
3) To evaluate possible adverse events, complications
and side effects.
According to these specific aims, we propose the fol-
lowing hypotheses:
1) For our primary outcome, we assume that the lower
limit of the 95% confidence interval (95% CI) of the
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null hypothesis states that the 95% CI of first
attempt success rate is below 0.9.
2) Successful tracheal intubation takes more time using
unguided VLS compared with the other VLS devices
that guide the tube towards the tracheal opening.
The secondary null hypothesis states that there is no
statistically significant difference in time until
intubation success between a guided and an
unguided VLS (two-sided). Other secondary
outcome-hypotheses include that the overall attempt
success rates are higher in guided VLS compared
with unguided VLS.
3) Minor airway injury rates are within a maximum of
10% comparing guided vs. unguided VLS. The null
hypothesis states that the differences of minor
airway injury rates are higher than 10%.
Methods/design
Study design
The SWIVIT trial is a prospective, patient-blinded, mul-
ticenter, randomized controlled trial at the anesthesia
departments of the University Hospital of Bern, the
University Hospital of Lausanne and the University
Hospital of Geneva, all in Switzerland.
Patient population
With ethics committee approval (KEK Bern ref. nr. 106/12
on 11 September 2012; Chairperson: Prof. Dr. N. Tueller)
and written informed consent, we will include adult pa-
tients of both genders, ASA (American Society of Anes-
thesiologists) physical status I to III, and scheduled at one
of the participating hospitals for elective surgery under
general anesthesia requiring tracheal intubation.
Patients are not eligible if they are at risk for aspiration
(non-fasted, severe gastro-esophageal reflux disease, hiatal
hernia), with known or presumed difficult airways (body
mass index >35 kg/m2, Mallampati >III, thyromental dis-
tance <6 cm, interincisor distance <3.5 cm [11], known
difficult mask ventilation or difficult laryngoscopy, or
scheduled for awake tracheal intubation), or if they refuse
to participate or are unable to give informed consent.
Sample size calculation
Most previous studies have based sample size calcula-
tions on differences of the intubation difficulty score
(IDS), developed by Adnet in 1997 for direct laryngos-
copy [12]. However, a retrospective study by McElwain
has raised concerns about the validity of the IDS with
VLS [13]. The most important outcome parameter for
VLS or any guided intubation devices is the success rate.
Most available data are from patients with normal air-
way anatomy and, therefore, not comparable with our
setting. Only one study immobilized the patients’ neckswith collars to investigate the C-MAC in 43 patients.
That study found an overall success rate of 88% [10].
This is an unacceptable low success rate for the manage-
ment of a difficult airway, but the study was underpow-
ered: we calculated the 95% CI in that study to be 0.75
to 0.95 for overall success rate.
In order to rate an intubation device as “successful”, we
define that the lower limit of the 95% CI should not be
smaller than 0.9. We based our sample size on these
values, congruent with our findings in a small pilot sam-
ple. We calculated the necessary sample size to obtain a
distance of 0.05 to the expected success rate of 0.95, pro-
vided a probability of 0.95 and a power of 80% (SAS v.9.1,
SAS Institute Inc., Cary, NC, USA). A total of 107 patients
per device are necessary for this lower limit of 0.9. A total
of 642 (6 × 107) patients will be necessary based on these
assumptions, which leads us to include 720 patients to
compensate for dropouts or missing data.
Secondary endpoints include parametric data, such as
time necessary until success. Time until success has var-
ied widely among different devices in published studies.
Furthermore, that parameter seems to be influenced by
the anesthesia provider. Therefore, we based our sample
size calculation on first attempt success rate.
Because available data about our primary outcome, the
first attempt success rate in a simulated difficult airway
scenario, are scarce, we will recalculate sample size after
the first 120 patients, based upon the values obtained
from the first 20 patients for each device. In order to re-
duce bias, all participating investigators will remain un-
aware of results obtained from these 120 patients.
We will compare time to intubate in unguided vs.
guided VLS as the secondary outcome. There are not
sufficient data available to calculate sample size for this
secondary outcome parameter. Therefore, we base our
sample size calculation on effect size: based on an esti-
mated medium effect size (Cohen’s d of 0.5; assuming
normal distribution), 64 samples per group are neces-
sary, given a 0.05 level (P = 0.05) and 80% power. Be-
cause our primary outcome requires 107 patients per
group, we are well within the necessary sample size even
for this secondary outcome parameter.
Experience with the device is expected to be a major
confounding factor. Only a limited number of experi-
enced anesthesiologists at each study center will perform
the intubation. To avoid a learning curve bias and to
minimize variation in the performance, only anesthesiol-
ogists who have intubated patients without any airway
pathology several times with each device until they feel
competent with the devices will participate. We did not
set a priori a fixed figure of intubations for each device
because the individual experience with different devices
is very divergent between the study centers and the par-
ticipating anesthesiologists. Ideally, experience with the
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recorded. We limit participants per center to a max-
imum of four physicians.
Statistical analysis
For the primary outcome, it will be analyzed for each laryn-
goscope whether the 95% confidence interval of its primary
success is below 0.9. For the secondary outcome parameters,
the data distribution will determine which statistical test will
be used. For frequencies (for example, number of required
manipulations, overall attempt success, complications) chi-
square test or Fisher’s exact test will be used. Parametric
data will be analyzed using ANOVA; for non-parametric
continuous data Kruskal-Wallis test will be used. For com-
parison between two devices, we will use Student’s t-testRand
Induction
Application of extrication c
Intubation attempt
Successful first intubation 
attempt Second intubation attem
Successful second intubation 
attempt
Fail
Third 
Successful third intuba
attempt
Ina
Figure 1 CONSORT flow diagram.and Mann-Whitney’s u-test, as appropriate. We will do a
priori comparisons of the time necessary until success be-
tween the unguided VLS and any of the guided VLS.
Data will be presented as mean with standard deviation,
median and interquartile range, or number and percent.
Effect sizes (with 95% CI) will be reported as Cohen’s d for
interval data and as odds ratio for proportions. A probabil-
ity of 0.05 is considered as statistically significant.
The patient flow diagram according CONSORT guide-
lines is provided in Figure 1.
Detailed study plan
Consent procedure
Patients will be recruited from the operating room schedule
of the corresponding hospitals. Written, informed consentAssessed for eligibility
omized to 1 of 6 VLS
ollar
pt
ed second intubation 
attempt
attempt with other VLS
tion 
Failed third intubation attempt: 
Remove collar.
- Any VLS
- Direct laryngoscopy
- Supraglottic airway device 
- Rigid fiberoptic stylet
- Flexible fiberoptic scope
dequate ventilation
Lost after randomization
Excluded
- Not meeting inclusion criteria
- Declined to participate
- Other reasons
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gery. All participants will be given a copy of the Patient In-
formation Sheet and be specifically informed that they may
decline to participate in or withdraw from the study at any
time.
Allocation of patients
Patients with written informed consent are randomly allo-
cated to one of the six devices. The allocation sequence
will be generated using online randomization software
(http://randomization.com) in blocks of 30 intubations for
the devices and stratified for each participating center and
for each physician. The allocation will be concealed in
sealed, opaque, sequentially numbered envelopes and will
not be opened until the patient is anesthetized.
Clinical study procedure
Premedication will be according to the standard operat-
ing procedures of the participating centers. Standard
non-invasive monitoring includes ECG, non-invasive ar-
terial blood pressure, oxygen saturation (SpO2), end-
tidal CO2 and volatile anesthetic level if applicable. A
bispectral index (BIS, Aspect Medical Systems, Nor-
wood, MA, USA) or a different processed EEG monitor-
ing will be used whenever available. Anesthesia will be
induced with propofol 1.5 to 3 mg/kg body weight and
fentanyl 1 to 2 mcg/kg body weight. After facemask ven-
tilation is established, neuromuscular blocking agents
(rocuronium 0.6 mg/kg body weight) will be given and
appropriate action monitored by neuro-stimulation. The
inter-incisor distance at maximum mouth opening will
be measured while the patient is asleep. Then, the extri-
cation collar (Stifneck™, Laerdal, Copenhagen, Denmark)
will be properly adjusted, and a self-adhesive tape will be
used to fix the head on the operating table, as done in
an earlier study by our group [6]. The inter-incisor dis-
tance will be measured at maximal mouth opening
aiming at a mouth opening between 20 to 25 mm.
If mask ventilation remains adequate and a sufficient
level of anesthesia is confirmed (BIS <55, stable hemo-
dynamic parameters, unresponsiveness to jaw thrust), the
tracheal intubation will be performed with the help of one
of the six VLS, according to randomization.
Selection of tracheal tube size (Mallinckrodt Hi-Contour
Oral/Nasal Tracheal Tube Cuffed, Covidien, Hazelwood,
MO, USA)
Women: 6.5 mm ID (internal diameter)
Men: 7.5 mm ID
Selection of blade size
1) Airtraq: Size #2 in women (6.5 mm tracheal tube
does not fit in size #3 device), size #3 in men2) A. P. Advance: Difficult airway blade for guided
intubation
3) C-MAC: D-blade. Additionally, a pre-shaped stylet
(shaped according to the decision of the consultant
anesthesiologist) will be used for tracheal insertion.
4) GlideScope: GVL single use blade #3 with reusable
GlideScope stylet for tracheal tube
5) King Vision: Blade #3 (channeled)
6) McGrath MAC: Disposable McGrath MAC blade.
Additionally, a pre-shaped stylet (shaped according
to the decision of the consultant anesthesiologist)
will be used for tracheal insertion.
The primary endpoint is successful tracheal intubation
confirmed by capnography (CO2 monitoring). Further
management of anesthesia is according to the consultant
anesthesiologist.
Device failure
A device failure is defined as two unsuccessful intub-
ation attempts with a maximum of 180 seconds for each
attempt while oxygen saturation remains >90%. The in-
tubation attempt is allowed to continue if the laryngeal
opening is identified after 180 seconds and the patient
does not desaturate (SpO2 >90%). However, this will not
count as success at the first attempt, but as an overall at-
tempt success. After the second unsuccessful attempt, a
third and last attempt will be performed with another
device, chosen according to the decision of the attending
anesthesiologist with the rigid collar in place. In case of
failure of the second device, further airway management
will be according to the decision of the attending
anesthesiologist, and without the rigid collar.
Break-up criteria (leading to removal of the rigid collar)
– Primary and secondary VLS device failure
– Bronchospasm, injury
– Technical failure of the intubation devices during
insertion attempt (for example, light bulb failure or
monitor failure)
If a break-up criterion is reached, the extrication collar
will be removed, the patient ventilated if necessary and the
trachea will be intubated via either the randomized device
(one attempt) or any other further airway manage-
ment device, according to the attending anesthesiologist.
The attending anesthesiologist may choose another
airway management strategy once a break-up criterion is
reached.
Measurements
– Insertion success (first and second attempt success rate).
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Lung ventilation through the cuffed tracheal tube, con-
firmed by end-tidal CO2.
– Time necessary for completion of the first attempt
intubation, second attempt (if applicable) and overall
intubation (calculated as the sum of the first and, if
applicable, second attempt).
Definition of time
Time necessary until success is measured from the time
the facemask is taken away from the face until the
end-tidal CO2 curve appears on the monitor of the
respirator. Time for each attempt is measured
separately.
– Cormack-Lehane (CL) grade [14] at laryngoscopy
(not developed for indirect laryngoscopy, but
necessary for the calculation of the IDS).
– Inter-incisor distance before induction of anesthesia
and after placement of the collar to measure
maximum mouth opening and the reduction of
mouth opening by the collar (collar adjusted to
permit a minimal opening of 18 mm, according to
the minimal requirements for Airtraq and King
Vision)
– Number of optimization maneuvers required
(cricoid pressure or BURP, backward, upward,
rightward pressure), second assistant, adjustment of
head positioning) to aid tracheal intubation [15].
– View on the glottic opening in percent (%) as judged
by the operator: Percentage of Glottic Opening
(POGO) Score [16].
– Adverse events: cardiovascular extremes: any hypo-/
hypertension and tachycardia/ bradycardia
exceeding 20% from baseline. Blood on device, and
injury during intubation attempt, suspicion of
aspiration/regurgitation (gastric fluid in the
ventilation tube or in the hypopharynx), hypoxia
(SpO2 <90%), bronchospasm, airway obstruction or
any other form of stridor, coughing, dental, tongue
or lip trauma.
– Technical problems with the device, such as fogging,
impeded vision and monitor/light source failure.
– The Intubation Difficulty Scale (IDS) score will be
calculated as previously published [12], using the
following parameters: number of attempts and
operators, alternative techniques, Cormack-Lehane
grade, lifting force, laryngeal pressure and vocal cord
mobility.
– Demographic and perioperative data: sex, age,
weight and body mass index, dentition, surgical
procedure/ duration, duration of anesthesia, date/
time of hospital discharge.Postoperative evaluation by blinded personnel
After anesthesia, the recovery room nurse (blinded
about randomization) will use a checklist to assess for
any airway trauma. The checklist, which includes ques-
tions about active oral bleeding, coughing blood, blood-
stained saliva, sore throat, pain when swallowing,
coughing, postoperative nausea and hoarseness, follows
a 3-graded assessment by the patient (mild, moderate,
severe). Timing of this assessment will be standardized
to one hour after post-anesthesia care unit admission. If
patients are extubated in the intensive care unit (ICU),
the ICU nurse will make the assessments. On postopera-
tive day one, a member of the study personnel will make
a further assessment, using the same checklist. In case of
ambulatory surgery, assessment will be done by tele-
phone. The investigator will be unaware of the
randomization, any problems encountered during intub-
ation or surgery, and will be blinded about the perform-
ance of the airway device.
Data collection techniques
All clinical data will be collected by a research assistant
at bedside, using digital data recording devices (tablets).
In case of device failure, a back-up paper form will be
available. All data will be sent to a secure, central data
storage immediately after the closure of the local case
report form.
Ethical approval
The SWIVIT randomized controlled trial has been ap-
proved by the ethic committee of the canton of Bern
(KEK Bern ref. nr. 106/12 on 11 September 2012).
A summarizing study flow chart is provided in Figure 2.
Discussion
According to the latest national audit in anesthesia in the
UK, major adverse events are estimated to be as high as 1
in 5,500 anesthesia cases, leading to brain damage and
even death [1]. Airway management was deemed to be
good in only 19% of these cases. This is an unacceptable
high failure rate for our patients’ safety. Therefore, new
and supposedly better devices to manage the difficult air-
way are necessary and continue to enter the market, often
without thorough evaluation of their efficacy. In case of
use of such devices in a difficult airway situation, it is vital
to know which device will perform best. While VLS are
marketed to facilitate the tracheal intubation in difficult
airway management, there are no adequately powered data
available comparing VLS in real difficult airway situations
or, at least, adequately simulated difficult airway models.
We intend to deliver this evidence. This will be for the
benefit and safety of patients presenting with an expected
or unexpected difficult airway needing general anesthesia
for surgery or interventions.
Figure 2 Study flow chart.
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Because sample size has been calculated based on rela-
tively vague figures, some adjustments in the total, ne-
cessary sample size may have to be incorporated when
we re-calculate our sample size after the first 120 pa-
tients as per protocol. However, the statistical calculation
is sound, and our assumptions are based on highly prob-
able clinical expectations. Furthermore, the results of
our study will be of clinical relevance regardless of
whether our primary hypothesis will be confirmed or
not and the much-feared “negative results” should be of
no concerns in this study.Generalizability
In this clinical trial, we will use a statistical model that may
be incorporated in future trials as well. Most clinical airway
studies seek to prove a difference between devices, or pos-
tulate agreement within pre-defined values, some are
designed as so called “non-inferiority” trails. In this study,
we pre-define an important clinical value as a benchmark
on which all devices studied are compared with the 90%
minimal first attempt success rate. We believe an airway
device should strive for this success rate, although that
would still mean a failure in 1 out of 10. However, standard
procedures in the difficult airway model used for this study
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goscopy succeeds only in 39.5% of cases [17] and rigid
fiberoptics fail in 9 to 14% (own data, not published yet).
Flexible fiberoptic intubation would be the method of
choice, however, it is highly operator dependent and time
consuming [18], and showed recently a not that impressive
first attempt success rate of only 79% [19].
Trial status
At the time of submission, the study was actively enrol-
ling patients. Fewer than 10 patients had been enrolled
in total in all three centers.
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